secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2025-03-26T23:59:59+00:00
Accession:  0000950170-25-044842
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health raises $3.45M via convertible notes; CEO & insiders participate
-----------------------------------------------------------------------------

- $3.448M aggregate principal convertible notes at 6% interest, 3-month maturity, convertible into common stock at ~$5.54/share.
- Insiders (CEO Conte, CFO, board members) purchase $535K of notes, also receive warrants at $5.43 exercise price.
- Warrants exercisable immediately, expire in 5 years; up to 622,598 warrant shares plus 622,598 conversion shares.
- Proceeds for working capital; H.C. Wainwright placement agent with 7% cash fee and warrants.
- Expected close March 27, 2025; registration rights agreement requires filing by April 15, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025044842/0000950170-25-044842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025044842/jagx-20250326.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-044842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer